Andrew Kuykendall, MD, reviews VERIFY trial that led to FDA approval of rusfertide in polycythemia vera.
Melissa Venditti
Advertisement
Melissa Venditti is a content producer for Targeted Oncology.
Articles by Melissa Venditti
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Oncologists Debate Role of On-Body Injector for Transplant-Ineligible Myeloma
2
MC001 Receives FDA Fast Track Designation in Pancreatic Cancer
3
Vilamakitug Meets Phase 2 Efficacy Criterion in Refractory Metastatic Colorectal Cancer
4
Dostarlimab Receives FDA Approval for MSI-H/dMMR Locally Advanced Rectal Cancer
5